Clinical Trials Arena is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Most Read

  1. May’s top news stories
  2. Lack of CMO availability threatens cell and gene therapy development
  3. CD47-targeted therapies: the breast cancer mop?
  4. Through CRISPR gene editing we can change the nature of our species
  5. Could groundbreaking gene therapies offer a breakthrough to retinal disease sufferers?

Latest Content

Soliris – Treatment for PNH, aHUS, gMG, and NMOSD

Soliris (eculizumab) is a drug indicated for the treatment of paroxysmal nocturnal haemoglobinuria (PNH), atypical haemolytic uremic syndrome (aHUS), generalised myasthenia gravis (gMG), and neuromyelitis optica spectrum disorder (NMOSD).

Latest News

Close
Close
Close

Go Top